Literature DB >> 22101961

Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium.

James M Gold1, Deanna M Barch, Cameron S Carter, Steven Dakin, Steven J Luck, Angus W MacDonald, J Daniel Ragland, Charan Ranganath, Ilona Kovacs, Steven M Silverstein, Milton Strauss.   

Abstract

The goal of the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia (CNTRACS) Consortium was to develop measures of discrete cognitive processes, allowing for the interpretation of specific deficits that could be linked to specific neural systems. Here we report on the intertask, clinical, and functional correlates of the 4 tasks that were investigated in large groups of patients with schizophrenia (>100) and healthy controls (>73) at 5 sites across the United States. In both healthy and patient groups, the key dependent measures from the CNTRACS tasks were minimally intercorrelated, suggesting that they are measuring discrete abilities. Correlations were examined between CNTRACS tasks and measures of functional capacity, premorbid IQ, symptom severity, and level of community functioning. Performance on tasks measuring relational memory encoding, goal maintenance, and visual gain control were correlated with premorbid IQ and the former 2 tasks with the functional capacity. Goal maintenance task performance was negatively correlated with negative symptom severity and informant reports of community function. These correlations reflect the relationship of specific abilities with functional outcome. They are somewhat lower than functional outcome correlations observed with conventional neuropsychological tests that confound multiple cognitive and motivational deficits. The measures of visual integration and gain control were not significantly correlated with clinical symptoms or function. These results suggest that the CNTRACS tasks measure discrete cognitive abilities, some of which relate to aspects of functional capacity/outcome in schizophrenia.

Entities:  

Mesh:

Year:  2011        PMID: 22101961      PMCID: PMC3245578          DOI: 10.1093/schbul/sbr142

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  35 in total

1.  The dorsolateral prefrontal cortex contributes to successful relational memory encoding.

Authors:  Linda J Murray; Charan Ranganath
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

Review 2.  Performance-based measures of functional skills: usefulness in clinical treatment studies.

Authors:  Philip D Harvey; Dawn I Velligan; Alan S Bellack
Journal:  Schizophr Bull       Date:  2007-05-09       Impact factor: 9.306

3.  Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.

Authors:  Dwight Dickinson; James M Gold
Journal:  Schizophr Bull       Date:  2007-08-16       Impact factor: 9.306

4.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

5.  Self-assessment of functional status in schizophrenia.

Authors:  Christopher R Bowie; Elizabeth W Twamley; Hannah Anderson; Brooke Halpern; Thomas L Patterson; Philip D Harvey
Journal:  J Psychiatr Res       Date:  2006-10-02       Impact factor: 4.791

Review 6.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

7.  Word production in schizophrenia and its relationship to positive symptoms.

Authors:  J G Kerns; H Berenbaum; D M Barch; M T Banich; N Stolar
Journal:  Psychiatry Res       Date:  1999-07-30       Impact factor: 3.222

Review 8.  Perceptual organization in schizophrenia spectrum disorders: empirical research and theoretical implications.

Authors:  Peter J Uhlhaas; Steven M Silverstein
Journal:  Psychol Bull       Date:  2005-07       Impact factor: 17.737

9.  Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.

Authors:  Christopher R Bowie; Winnie W Leung; Abraham Reichenberg; Margaret M McClure; Thomas L Patterson; Robert K Heaton; Philip D Harvey
Journal:  Biol Psychiatry       Date:  2007-07-27       Impact factor: 13.382

Review 10.  Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.

Authors:  Cameron S Carter; Deanna M Barch
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

View more
  45 in total

1.  Cognitive neuroscience test reliability and clinical applications for schizophrenia.

Authors:  James Gold
Journal:  Schizophr Bull       Date:  2012-01       Impact factor: 9.306

2.  The clinical translation of a measure of gain control: the contrast-contrast effect task.

Authors:  Deanna M Barch; Cameron S Carter; Steve C Dakin; James Gold; Steven J Luck; Angus Macdonald; John D Ragland; Steven Silverstein; Milton E Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

3.  Visual context processing in schizophrenia.

Authors:  Eunice Yang; Duje Tadin; Davis M Glasser; Sang Wook Hong; Randolph Blake; Sohee Park
Journal:  Clin Psychol Sci       Date:  2013-01-01

4.  Explicit and implicit reinforcement learning across the psychosis spectrum.

Authors:  Deanna M Barch; Cameron S Carter; James M Gold; Sheri L Johnson; Ann M Kring; Angus W MacDonald; Diego A Pizzagalli; J Daniel Ragland; Steven M Silverstein; Milton E Strauss
Journal:  J Abnorm Psychol       Date:  2017-04-13

5.  Adapting social neuroscience measures for schizophrenia clinical trials, part 3: fathoming external validity.

Authors:  Charles M Olbert; David L Penn; Robert S Kern; Junghee Lee; William P Horan; Steven P Reise; Kevin N Ochsner; Stephen R Marder; Michael F Green
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

6.  Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.

Authors:  Michael F Green; Junghee Lee; Kevin N Ochsner
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

7.  Adapting social neuroscience measures for schizophrenia clinical trials, Part 2: trolling the depths of psychometric properties.

Authors:  Robert S Kern; David L Penn; Junghee Lee; William P Horan; Steven P Reise; Kevin N Ochsner; Stephen R Marder; Michael F Green
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

8.  Neural correlates of global and specific cognitive deficits in schizophrenia.

Authors:  Robert J Jirsaraie; Julia M Sheffield; Deanna M Barch
Journal:  Schizophr Res       Date:  2018-06-25       Impact factor: 4.939

9.  Improving Measurement Precision in Experimental Psychopathology Using Item Response Theory.

Authors:  Leah M Feuerstahler; Niels Waller; Angus MacDonald
Journal:  Educ Psychol Meas       Date:  2019-12-06       Impact factor: 2.821

10.  Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different.

Authors:  A Owoso; C S Carter; J M Gold; A W MacDonald; J D Ragland; S M Silverstein; M E Strauss; D M Barch
Journal:  Psychol Med       Date:  2013-03-25       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.